Our Members

Roche Diagnostics India

Roche is the world’s largest biotech company. Roche Diagnostics India Pvt. Ltd. established in the year 2002, has offices located in Chennai, Delhi, Kolkata and Mumbai with over 400 employees and present in 450+ cities across the country. The company’s broad range of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions and cover early detection, targeted screening, evaluation, and disease monitoring. Roche Diagnostics India works with the objective of “Doing now what patients need next”, thus preparing for the nation’s future healthcare needs.

schülke

“For almost 135 years, Schülke & Mayr GmbH (schülke) has been one of the world’s leading manufacturers of products and services in the fields of infection prevention and treatment as well as hygiene and wound care. With our innovative developments, we as a company make a significant contribution to today’s hygiene standards.

With our strong brands, such as octenisept®, kodan®, desderman® and Microshield®, we are one of the international market leaders in the field of wound and mucous membrane antiseptics as well as hand and surface disinfection in German hospitals.

With our wide range of high-quality and innovative products, expert advice and reliable service, we offer holistic concepts for the treatment and prevention of infections in professional healthcare, in the pharmaceutical sector and for end consumers – worldwide. People in more than 80 countries around the world rely on our products every day.

A look at our history illustrates the pioneering spirit that is deeply rooted in our company: in 1889, the ship captain Rudolf Schülke and the businessman Julius Mayr founded Schülke & Mayr GmbH in Hamburg and – after thorough testing for suitability by Robert Koch – acquired the world patent for the production of the first disinfectant Lysol.

The use of this product made it possible to combat the cholera epidemic raging in Hamburg in 1892. The success is documented by a certificate from the Hanseatic city.

We have always relied on our strong research department and have continuously launched other successful products on the market. We achieved another milestone with the approval of the drug octenisept®: schülke revolutionized wound care in 1990 by launching a colorless and painless wound antiseptic on the market for the first time.

Since then, octenisept® has become an integral part of the professional medical field and is used in many households as a wound antiseptic for young and old.

Infectious diseases pose major challenges for the healthcare system and society. Infectious pathogens know no borders – this has always been true and is all the more important in today’s globalized world! At the latest since the outbreak of the COVID-19 pandemic, this has also become widely known.

schülke has over 20 subsidiaries and production sites in Germany (schülke), France (Bioxal) and Brazil (Vic Pharma). Companies with specific fields of application and markets such as Prosenio GmbH, Vesismin Health and Wet Wipe A/S are also part of the schülke Group*.”

Septodont

Septodont India was established in 1999 as a fully owned subsidiary of Septodont France, inheriting the legacy and philosophy set by its founders. Renowned for its commitment to quality, Septodont India manufactures dental products that serve the dental fraternity across various countries, including the Indian sub-continent, France, the US, Vietnam, Australia, and Brazil.

Smith & Nephew Healthcare

As a 160 years old UK-headquartered medical devices manufacturer and multinational organization, Smith & Nephew supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients.

We are one of the global leaders in:

• Orthopaedics Reconstruction – joint replacement systems for knees, hips and shoulders
• Advanced Wound Management – wound care treatment and prevention products used to treat hard-to-heal wounds
• Sports Medicine – minimally invasive surgery of the joints
• Trauma & Extremities – products that help repair fractures and deformities

With our annual sales of close to 4.6 billion USD (2015), we have around 15,000 employees around the world, who embody Innovation, Trust and Performance as the core values of Smith & Nephew.

We are a constituent of the UK’s FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange.

Smith & Nephew has frequently made it to the Forbes’ list of the World’s 100 Most Innovative Companies (2013, 2015, 2016).

Smith & Nephew takes a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. Our recent initiatives include the launch of our mid-tier value segment of products in orthopedics and wound management (which includes the legacy range of our acquired Sushrut-Adler business in India), acquisitions of Arthrocare (to strengthen our performance in Sports Medicine) and Blue Belt Technologies (giving us a leading position in the fast-growing area of robotics-assisted orthopaedic surgery). In addition, we make major investments in R&D as well as Educational platforms and Evidence generation, which have been our major drivers in India and emerging markets, where providing affordable quality healthcare, training and product and business model innovations are the key to growth.

A testament to the positive difference that we have made is our recent recognition (2016) by the Economic Times as one of the Best Healthcare Brands in India.

Solventum​

Solventum is a new healthcare company built from a legacy of innovation and dedicated to enabling better, smarter, safer healthcare to improve lives. With more than 70 years of delivering healthcare innovations, we continue to move the industry forward by listening closely to you. Solventum is pioneering game-changing innovations in the healthcare market through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.